Adjunctive Cannabidiol for Recovery From Opioid Study

PHASE3RecruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

June 13, 2025

Primary Completion Date

July 15, 2027

Study Completion Date

August 15, 2027

Conditions
Opioid Use Disorder (OUD)
Interventions
DRUG

Cannabidiol

1 capsule CBD 200mg

DRUG

Placebo

Bovine Gel Placebo capsule

Trial Locations (1)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

International Center for Health Outcomes and Innovation Research

OTHER

collaborator

Brains Bioceutical

UNKNOWN

lead

Icahn School of Medicine at Mount Sinai

OTHER